Innovation Pharmaceuticals

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch IPIX and buy or sell other stocks, ETFs, and their options commission-free!

About IPIX

Innovation Pharmaceuticals, Inc. is a clinical stage biotechnology company, which engages in the development of therapies with anti-infective, oncology, anti-inflammatory, and dermatology applications. It focuses on its antifungal drug candidate called Brilacidin. 

CEO
Leo Ehrlich
CEOLeo Ehrlich
Employees
4
Employees4
Headquarters
Wakefield, Massachusetts
HeadquartersWakefield, Massachusetts
Founded
2007
Founded2007
Employees
4
Employees4

IPIX Key Statistics

Market cap
53.73K
Market cap53.73K
Price-Earnings ratio
—
Price-Earnings ratio—
Dividend yield
—
Dividend yield—
Average volume
90.22K
Average volume90.22K
High today
$0.0001
High today$0.0001
Low today
$0.0001
Low today$0.0001
Open price
$0.0001
Open price$0.0001
Volume
3.70K
Volume3.70K
52 Week high
$0.05
52 Week high$0.05
52 Week low
$0.00
52 Week low$0.00

Stock Snapshot

The current Innovation Pharmaceuticals(IPIX) stock price is $0.00, with a market capitalization of 53.73K.

On 2026-10-05, Innovation Pharmaceuticals(IPIX) stock moved within a range of $0.00 to $0.00. With shares now at $0.00, the stock is trading 0.0% above its intraday low and 0.0% below the session's peak.

Trading activity shows a volume of 3.7K, compared to an average daily volume of 90.22K.

Over the past 52 weeks, Innovation Pharmaceuticals(IPIX) stock has traded between a high of $0.05 and a low of $0.00.

Over the past 52 weeks, Innovation Pharmaceuticals(IPIX) stock has traded between a high of $0.05 and a low of $0.00.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.